nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Temsirolimus—kidney cancer	0.0858	0.13	CbGbCtD
Oxybutynin—CYP2D6—Temsirolimus—kidney cancer	0.0526	0.0799	CbGbCtD
Oxybutynin—CYP3A4—Everolimus—kidney cancer	0.0495	0.0752	CbGbCtD
Oxybutynin—CYP2C8—Pazopanib—kidney cancer	0.0433	0.0658	CbGbCtD
Oxybutynin—CYP3A4—Temsirolimus—kidney cancer	0.0335	0.0508	CbGbCtD
Oxybutynin—CYP3A5—Erlotinib—kidney cancer	0.0322	0.0488	CbGbCtD
Oxybutynin—CYP2C8—Erlotinib—kidney cancer	0.0309	0.047	CbGbCtD
Oxybutynin—CYP3A5—Paclitaxel—kidney cancer	0.0294	0.0447	CbGbCtD
Oxybutynin—CYP2C8—Paclitaxel—kidney cancer	0.0283	0.043	CbGbCtD
Oxybutynin—CYP2D6—Pazopanib—kidney cancer	0.0276	0.042	CbGbCtD
Oxybutynin—CYP3A5—Sorafenib—kidney cancer	0.0262	0.0397	CbGbCtD
Oxybutynin—CYP3A5—Vincristine—kidney cancer	0.0254	0.0385	CbGbCtD
Oxybutynin—CYP2C8—Sorafenib—kidney cancer	0.0251	0.0382	CbGbCtD
Oxybutynin—CYP3A5—Sunitinib—kidney cancer	0.0212	0.0322	CbGbCtD
Oxybutynin—CYP2D6—Erlotinib—kidney cancer	0.0197	0.0299	CbGbCtD
Oxybutynin—CYP3A4—Pazopanib—kidney cancer	0.0176	0.0267	CbGbCtD
Oxybutynin—CYP2D6—Sorafenib—kidney cancer	0.016	0.0243	CbGbCtD
Oxybutynin—CYP2D6—Vinblastine—kidney cancer	0.0158	0.024	CbGbCtD
Oxybutynin—CYP3A4—Erlotinib—kidney cancer	0.0125	0.019	CbGbCtD
Oxybutynin—CHRM3—ureter—kidney cancer	0.012	0.49	CbGeAlD
Oxybutynin—CYP3A4—Paclitaxel—kidney cancer	0.0115	0.0174	CbGbCtD
Oxybutynin—CYP3A4—Sorafenib—kidney cancer	0.0102	0.0155	CbGbCtD
Oxybutynin—CYP3A4—Vinblastine—kidney cancer	0.0101	0.0153	CbGbCtD
Oxybutynin—CYP3A4—Vincristine—kidney cancer	0.0099	0.015	CbGbCtD
Oxybutynin—CYP2D6—Doxorubicin—kidney cancer	0.00973	0.0148	CbGbCtD
Oxybutynin—CYP3A4—Sunitinib—kidney cancer	0.00826	0.0125	CbGbCtD
Oxybutynin—CYP3A4—Doxorubicin—kidney cancer	0.00619	0.00939	CbGbCtD
Oxybutynin—CYP3A4—urine—kidney cancer	0.00214	0.0875	CbGeAlD
Oxybutynin—CYP2D6—urine—kidney cancer	0.00211	0.0861	CbGeAlD
Oxybutynin—CHRM3—renal system—kidney cancer	0.000953	0.0389	CbGeAlD
Oxybutynin—CHRM3—kidney—kidney cancer	0.000921	0.0376	CbGeAlD
Oxybutynin—CYP2C8—renal system—kidney cancer	0.000773	0.0316	CbGeAlD
Oxybutynin—CYP3A5—nephron tubule—kidney cancer	0.000767	0.0314	CbGeAlD
Oxybutynin—CYP2C8—kidney—kidney cancer	0.000747	0.0305	CbGeAlD
Oxybutynin—CYP3A5—renal system—kidney cancer	0.000698	0.0285	CbGeAlD
Oxybutynin—CYP3A5—kidney—kidney cancer	0.000674	0.0276	CbGeAlD
Oxybutynin—CYP3A5—cortex of kidney—kidney cancer	0.000657	0.0268	CbGeAlD
Oxybutynin—CYP3A4—renal system—kidney cancer	0.000524	0.0214	CbGeAlD
Oxybutynin—CYP2D6—renal system—kidney cancer	0.000515	0.0211	CbGeAlD
Oxybutynin—CYP3A4—kidney—kidney cancer	0.000506	0.0207	CbGeAlD
Oxybutynin—CYP2D6—kidney—kidney cancer	0.000498	0.0204	CbGeAlD
Oxybutynin—Flushing—Capecitabine—kidney cancer	0.000135	0.000454	CcSEcCtD
Oxybutynin—Cough—Paclitaxel—kidney cancer	0.000135	0.000453	CcSEcCtD
Oxybutynin—Asthenia—Sunitinib—kidney cancer	0.000134	0.000453	CcSEcCtD
Oxybutynin—Nausea—Vinblastine—kidney cancer	0.000134	0.00045	CcSEcCtD
Oxybutynin—Somnolence—Gemcitabine—kidney cancer	0.000134	0.00045	CcSEcCtD
Oxybutynin—Convulsion—Paclitaxel—kidney cancer	0.000134	0.00045	CcSEcCtD
Oxybutynin—Affect lability—Doxorubicin—kidney cancer	0.000133	0.000449	CcSEcCtD
Oxybutynin—Migraine—Doxorubicin—kidney cancer	0.000133	0.000449	CcSEcCtD
Oxybutynin—Nausea—Everolimus—kidney cancer	0.000133	0.000449	CcSEcCtD
Oxybutynin—Diarrhoea—Sorafenib—kidney cancer	0.000133	0.000449	CcSEcCtD
Oxybutynin—Hypertension—Paclitaxel—kidney cancer	0.000133	0.000448	CcSEcCtD
Oxybutynin—Pruritus—Sunitinib—kidney cancer	0.000133	0.000446	CcSEcCtD
Oxybutynin—Angiopathy—Capecitabine—kidney cancer	0.000132	0.000444	CcSEcCtD
Oxybutynin—Arthralgia—Paclitaxel—kidney cancer	0.000131	0.000442	CcSEcCtD
Oxybutynin—Chest pain—Paclitaxel—kidney cancer	0.000131	0.000442	CcSEcCtD
Oxybutynin—Mediastinal disorder—Capecitabine—kidney cancer	0.000131	0.000441	CcSEcCtD
Oxybutynin—Anxiety—Paclitaxel—kidney cancer	0.000131	0.000441	CcSEcCtD
Oxybutynin—Face oedema—Doxorubicin—kidney cancer	0.000131	0.00044	CcSEcCtD
Oxybutynin—Decreased appetite—Gemcitabine—kidney cancer	0.000131	0.00044	CcSEcCtD
Oxybutynin—Hypersensitivity—Dactinomycin—kidney cancer	0.000131	0.00044	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00013	0.000439	CcSEcCtD
Oxybutynin—Arrhythmia—Capecitabine—kidney cancer	0.00013	0.000437	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00013	0.000437	CcSEcCtD
Oxybutynin—Discomfort—Paclitaxel—kidney cancer	0.00013	0.000437	CcSEcCtD
Oxybutynin—Fatigue—Gemcitabine—kidney cancer	0.00013	0.000437	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Vincristine—kidney cancer	0.00013	0.000436	CcSEcCtD
Oxybutynin—Dizziness—Sorafenib—kidney cancer	0.000129	0.000434	CcSEcCtD
Oxybutynin—Pain—Gemcitabine—kidney cancer	0.000129	0.000433	CcSEcCtD
Oxybutynin—Constipation—Gemcitabine—kidney cancer	0.000129	0.000433	CcSEcCtD
Oxybutynin—Nausea—Erlotinib—kidney cancer	0.000129	0.000433	CcSEcCtD
Oxybutynin—Dry mouth—Paclitaxel—kidney cancer	0.000128	0.000432	CcSEcCtD
Oxybutynin—Mood swings—Doxorubicin—kidney cancer	0.000128	0.000432	CcSEcCtD
Oxybutynin—Diarrhoea—Sunitinib—kidney cancer	0.000128	0.000432	CcSEcCtD
Oxybutynin—Mental disorder—Capecitabine—kidney cancer	0.000127	0.000429	CcSEcCtD
Oxybutynin—Asthenia—Dactinomycin—kidney cancer	0.000127	0.000429	CcSEcCtD
Oxybutynin—Confusional state—Paclitaxel—kidney cancer	0.000127	0.000427	CcSEcCtD
Oxybutynin—Blood creatinine increased—Doxorubicin—kidney cancer	0.000127	0.000427	CcSEcCtD
Oxybutynin—Malnutrition—Capecitabine—kidney cancer	0.000127	0.000426	CcSEcCtD
Oxybutynin—Erythema—Capecitabine—kidney cancer	0.000127	0.000426	CcSEcCtD
Oxybutynin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000126	0.000424	CcSEcCtD
Oxybutynin—Oedema—Paclitaxel—kidney cancer	0.000126	0.000424	CcSEcCtD
Oxybutynin—Abdominal pain—Vincristine—kidney cancer	0.000125	0.000422	CcSEcCtD
Oxybutynin—Liver function test abnormal—Doxorubicin—kidney cancer	0.000125	0.000421	CcSEcCtD
Oxybutynin—Infection—Paclitaxel—kidney cancer	0.000125	0.000421	CcSEcCtD
Oxybutynin—Flatulence—Capecitabine—kidney cancer	0.000125	0.00042	CcSEcCtD
Oxybutynin—Dry skin—Doxorubicin—kidney cancer	0.000124	0.000418	CcSEcCtD
Oxybutynin—Dysgeusia—Capecitabine—kidney cancer	0.000124	0.000417	CcSEcCtD
Oxybutynin—Dizziness—Sunitinib—kidney cancer	0.000124	0.000417	CcSEcCtD
Oxybutynin—Feeling abnormal—Gemcitabine—kidney cancer	0.000124	0.000417	CcSEcCtD
Oxybutynin—Shock—Paclitaxel—kidney cancer	0.000124	0.000417	CcSEcCtD
Oxybutynin—Vomiting—Sorafenib—kidney cancer	0.000124	0.000417	CcSEcCtD
Oxybutynin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000124	0.000417	CcSEcCtD
Oxybutynin—Nervous system disorder—Paclitaxel—kidney cancer	0.000123	0.000416	CcSEcCtD
Oxybutynin—Tachycardia—Paclitaxel—kidney cancer	0.000123	0.000414	CcSEcCtD
Oxybutynin—Rash—Sorafenib—kidney cancer	0.000123	0.000413	CcSEcCtD
Oxybutynin—Dermatitis—Sorafenib—kidney cancer	0.000123	0.000413	CcSEcCtD
Oxybutynin—Back pain—Capecitabine—kidney cancer	0.000122	0.000412	CcSEcCtD
Oxybutynin—Breast disorder—Doxorubicin—kidney cancer	0.000122	0.000412	CcSEcCtD
Oxybutynin—Skin disorder—Paclitaxel—kidney cancer	0.000122	0.000412	CcSEcCtD
Oxybutynin—Headache—Sorafenib—kidney cancer	0.000122	0.000411	CcSEcCtD
Oxybutynin—Diarrhoea—Dactinomycin—kidney cancer	0.000121	0.000409	CcSEcCtD
Oxybutynin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000121	0.000408	CcSEcCtD
Oxybutynin—Anorexia—Paclitaxel—kidney cancer	0.00012	0.000404	CcSEcCtD
Oxybutynin—Vision blurred—Capecitabine—kidney cancer	0.000119	0.000402	CcSEcCtD
Oxybutynin—Vomiting—Sunitinib—kidney cancer	0.000119	0.000401	CcSEcCtD
Oxybutynin—Rash—Sunitinib—kidney cancer	0.000118	0.000398	CcSEcCtD
Oxybutynin—Dermatitis—Sunitinib—kidney cancer	0.000118	0.000397	CcSEcCtD
Oxybutynin—Abdominal distension—Doxorubicin—kidney cancer	0.000118	0.000397	CcSEcCtD
Oxybutynin—Hypotension—Paclitaxel—kidney cancer	0.000118	0.000396	CcSEcCtD
Oxybutynin—Ill-defined disorder—Capecitabine—kidney cancer	0.000117	0.000395	CcSEcCtD
Oxybutynin—Headache—Sunitinib—kidney cancer	0.000117	0.000395	CcSEcCtD
Oxybutynin—Influenza—Doxorubicin—kidney cancer	0.000117	0.000394	CcSEcCtD
Oxybutynin—Asthma—Doxorubicin—kidney cancer	0.000117	0.000394	CcSEcCtD
Oxybutynin—Dysphagia—Doxorubicin—kidney cancer	0.000117	0.000394	CcSEcCtD
Oxybutynin—Hypersensitivity—Vincristine—kidney cancer	0.000117	0.000393	CcSEcCtD
Oxybutynin—Nausea—Sorafenib—kidney cancer	0.000116	0.00039	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000115	0.000386	CcSEcCtD
Oxybutynin—Malaise—Capecitabine—kidney cancer	0.000114	0.000384	CcSEcCtD
Oxybutynin—Insomnia—Paclitaxel—kidney cancer	0.000114	0.000383	CcSEcCtD
Oxybutynin—Asthenia—Vincristine—kidney cancer	0.000114	0.000383	CcSEcCtD
Oxybutynin—Syncope—Capecitabine—kidney cancer	0.000114	0.000382	CcSEcCtD
Oxybutynin—Paraesthesia—Paclitaxel—kidney cancer	0.000113	0.000381	CcSEcCtD
Oxybutynin—Vomiting—Dactinomycin—kidney cancer	0.000113	0.00038	CcSEcCtD
Oxybutynin—Bronchitis—Doxorubicin—kidney cancer	0.000113	0.000379	CcSEcCtD
Oxybutynin—Somnolence—Paclitaxel—kidney cancer	0.000112	0.000377	CcSEcCtD
Oxybutynin—Palpitations—Capecitabine—kidney cancer	0.000112	0.000377	CcSEcCtD
Oxybutynin—Rash—Dactinomycin—kidney cancer	0.000112	0.000377	CcSEcCtD
Oxybutynin—Nausea—Sunitinib—kidney cancer	0.000111	0.000375	CcSEcCtD
Oxybutynin—Loss of consciousness—Capecitabine—kidney cancer	0.000111	0.000375	CcSEcCtD
Oxybutynin—Dyspepsia—Paclitaxel—kidney cancer	0.000111	0.000373	CcSEcCtD
Oxybutynin—Cough—Capecitabine—kidney cancer	0.00011	0.000372	CcSEcCtD
Oxybutynin—Dysuria—Doxorubicin—kidney cancer	0.000109	0.000369	CcSEcCtD
Oxybutynin—Decreased appetite—Paclitaxel—kidney cancer	0.000109	0.000369	CcSEcCtD
Oxybutynin—Hypertension—Capecitabine—kidney cancer	0.000109	0.000368	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000109	0.000366	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000109	0.000366	CcSEcCtD
Oxybutynin—Fatigue—Paclitaxel—kidney cancer	0.000109	0.000365	CcSEcCtD
Oxybutynin—Diarrhoea—Vincristine—kidney cancer	0.000108	0.000365	CcSEcCtD
Oxybutynin—Pollakiuria—Doxorubicin—kidney cancer	0.000108	0.000364	CcSEcCtD
Oxybutynin—Asthenia—Gemcitabine—kidney cancer	0.000108	0.000363	CcSEcCtD
Oxybutynin—Arthralgia—Capecitabine—kidney cancer	0.000108	0.000363	CcSEcCtD
Oxybutynin—Chest pain—Capecitabine—kidney cancer	0.000108	0.000363	CcSEcCtD
Oxybutynin—Pain—Paclitaxel—kidney cancer	0.000108	0.000363	CcSEcCtD
Oxybutynin—Constipation—Paclitaxel—kidney cancer	0.000108	0.000363	CcSEcCtD
Oxybutynin—Anxiety—Capecitabine—kidney cancer	0.000107	0.000362	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000107	0.00036	CcSEcCtD
Oxybutynin—Discomfort—Capecitabine—kidney cancer	0.000106	0.000359	CcSEcCtD
Oxybutynin—Pruritus—Gemcitabine—kidney cancer	0.000106	0.000358	CcSEcCtD
Oxybutynin—Dry mouth—Capecitabine—kidney cancer	0.000105	0.000355	CcSEcCtD
Oxybutynin—Nausea—Dactinomycin—kidney cancer	0.000105	0.000355	CcSEcCtD
Oxybutynin—Dizziness—Vincristine—kidney cancer	0.000105	0.000353	CcSEcCtD
Oxybutynin—Infestation NOS—Doxorubicin—kidney cancer	0.000104	0.000352	CcSEcCtD
Oxybutynin—Infestation—Doxorubicin—kidney cancer	0.000104	0.000352	CcSEcCtD
Oxybutynin—Drowsiness—Doxorubicin—kidney cancer	0.000104	0.000352	CcSEcCtD
Oxybutynin—Confusional state—Capecitabine—kidney cancer	0.000104	0.000351	CcSEcCtD
Oxybutynin—Feeling abnormal—Paclitaxel—kidney cancer	0.000104	0.000349	CcSEcCtD
Oxybutynin—Oedema—Capecitabine—kidney cancer	0.000103	0.000348	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000103	0.000347	CcSEcCtD
Oxybutynin—Diarrhoea—Gemcitabine—kidney cancer	0.000103	0.000346	CcSEcCtD
Oxybutynin—Infection—Capecitabine—kidney cancer	0.000103	0.000346	CcSEcCtD
Oxybutynin—Stomatitis—Doxorubicin—kidney cancer	0.000102	0.000343	CcSEcCtD
Oxybutynin—Shock—Capecitabine—kidney cancer	0.000102	0.000342	CcSEcCtD
Oxybutynin—Urinary tract infection—Doxorubicin—kidney cancer	0.000101	0.000342	CcSEcCtD
Oxybutynin—Conjunctivitis—Doxorubicin—kidney cancer	0.000101	0.000342	CcSEcCtD
Oxybutynin—Nervous system disorder—Capecitabine—kidney cancer	0.000101	0.000341	CcSEcCtD
Oxybutynin—Tachycardia—Capecitabine—kidney cancer	0.000101	0.00034	CcSEcCtD
Oxybutynin—Vomiting—Vincristine—kidney cancer	0.000101	0.000339	CcSEcCtD
Oxybutynin—Skin disorder—Capecitabine—kidney cancer	0.0001	0.000338	CcSEcCtD
Oxybutynin—Urticaria—Paclitaxel—kidney cancer	0.0001	0.000337	CcSEcCtD
Oxybutynin—Rash—Vincristine—kidney cancer	9.99e-05	0.000337	CcSEcCtD
Oxybutynin—Dermatitis—Vincristine—kidney cancer	9.98e-05	0.000336	CcSEcCtD
Oxybutynin—Haematuria—Doxorubicin—kidney cancer	9.95e-05	0.000335	CcSEcCtD
Oxybutynin—Abdominal pain—Paclitaxel—kidney cancer	9.95e-05	0.000335	CcSEcCtD
Oxybutynin—Headache—Vincristine—kidney cancer	9.93e-05	0.000334	CcSEcCtD
Oxybutynin—Epistaxis—Doxorubicin—kidney cancer	9.85e-05	0.000332	CcSEcCtD
Oxybutynin—Anorexia—Capecitabine—kidney cancer	9.85e-05	0.000332	CcSEcCtD
Oxybutynin—Sinusitis—Doxorubicin—kidney cancer	9.8e-05	0.00033	CcSEcCtD
Oxybutynin—Hypotension—Capecitabine—kidney cancer	9.65e-05	0.000325	CcSEcCtD
Oxybutynin—Vomiting—Gemcitabine—kidney cancer	9.56e-05	0.000322	CcSEcCtD
Oxybutynin—Rash—Gemcitabine—kidney cancer	9.48e-05	0.000319	CcSEcCtD
Oxybutynin—Dermatitis—Gemcitabine—kidney cancer	9.47e-05	0.000319	CcSEcCtD
Oxybutynin—Headache—Gemcitabine—kidney cancer	9.42e-05	0.000317	CcSEcCtD
Oxybutynin—Nausea—Vincristine—kidney cancer	9.41e-05	0.000317	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.41e-05	0.000317	CcSEcCtD
Oxybutynin—Rhinitis—Doxorubicin—kidney cancer	9.4e-05	0.000316	CcSEcCtD
Oxybutynin—Insomnia—Capecitabine—kidney cancer	9.34e-05	0.000315	CcSEcCtD
Oxybutynin—Hypoaesthesia—Doxorubicin—kidney cancer	9.33e-05	0.000314	CcSEcCtD
Oxybutynin—Pharyngitis—Doxorubicin—kidney cancer	9.3e-05	0.000313	CcSEcCtD
Oxybutynin—Paraesthesia—Capecitabine—kidney cancer	9.28e-05	0.000312	CcSEcCtD
Oxybutynin—Hypersensitivity—Paclitaxel—kidney cancer	9.27e-05	0.000312	CcSEcCtD
Oxybutynin—Urinary tract disorder—Doxorubicin—kidney cancer	9.26e-05	0.000312	CcSEcCtD
Oxybutynin—Oedema peripheral—Doxorubicin—kidney cancer	9.23e-05	0.000311	CcSEcCtD
Oxybutynin—Connective tissue disorder—Doxorubicin—kidney cancer	9.21e-05	0.00031	CcSEcCtD
Oxybutynin—Urethral disorder—Doxorubicin—kidney cancer	9.19e-05	0.000309	CcSEcCtD
Oxybutynin—Dyspepsia—Capecitabine—kidney cancer	9.09e-05	0.000306	CcSEcCtD
Oxybutynin—Visual impairment—Doxorubicin—kidney cancer	9.03e-05	0.000304	CcSEcCtD
Oxybutynin—Asthenia—Paclitaxel—kidney cancer	9.03e-05	0.000304	CcSEcCtD
Oxybutynin—Decreased appetite—Capecitabine—kidney cancer	8.98e-05	0.000302	CcSEcCtD
Oxybutynin—Nausea—Gemcitabine—kidney cancer	8.93e-05	0.000301	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Capecitabine—kidney cancer	8.92e-05	0.0003	CcSEcCtD
Oxybutynin—Fatigue—Capecitabine—kidney cancer	8.91e-05	0.0003	CcSEcCtD
Oxybutynin—Pruritus—Paclitaxel—kidney cancer	8.91e-05	0.0003	CcSEcCtD
Oxybutynin—Pain—Capecitabine—kidney cancer	8.83e-05	0.000297	CcSEcCtD
Oxybutynin—Constipation—Capecitabine—kidney cancer	8.83e-05	0.000297	CcSEcCtD
Oxybutynin—Eye disorder—Doxorubicin—kidney cancer	8.76e-05	0.000295	CcSEcCtD
Oxybutynin—Tinnitus—Doxorubicin—kidney cancer	8.74e-05	0.000294	CcSEcCtD
Oxybutynin—Flushing—Doxorubicin—kidney cancer	8.7e-05	0.000293	CcSEcCtD
Oxybutynin—Cardiac disorder—Doxorubicin—kidney cancer	8.7e-05	0.000293	CcSEcCtD
Oxybutynin—Diarrhoea—Paclitaxel—kidney cancer	8.61e-05	0.00029	CcSEcCtD
Oxybutynin—Feeling abnormal—Capecitabine—kidney cancer	8.51e-05	0.000287	CcSEcCtD
Oxybutynin—Angiopathy—Doxorubicin—kidney cancer	8.5e-05	0.000286	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Capecitabine—kidney cancer	8.45e-05	0.000284	CcSEcCtD
Oxybutynin—Mediastinal disorder—Doxorubicin—kidney cancer	8.45e-05	0.000284	CcSEcCtD
Oxybutynin—Arrhythmia—Doxorubicin—kidney cancer	8.37e-05	0.000282	CcSEcCtD
Oxybutynin—Dizziness—Paclitaxel—kidney cancer	8.32e-05	0.00028	CcSEcCtD
Oxybutynin—Mental disorder—Doxorubicin—kidney cancer	8.21e-05	0.000277	CcSEcCtD
Oxybutynin—Urticaria—Capecitabine—kidney cancer	8.21e-05	0.000276	CcSEcCtD
Oxybutynin—Abdominal pain—Capecitabine—kidney cancer	8.17e-05	0.000275	CcSEcCtD
Oxybutynin—Malnutrition—Doxorubicin—kidney cancer	8.16e-05	0.000275	CcSEcCtD
Oxybutynin—Erythema—Doxorubicin—kidney cancer	8.16e-05	0.000275	CcSEcCtD
Oxybutynin—Flatulence—Doxorubicin—kidney cancer	8.04e-05	0.000271	CcSEcCtD
Oxybutynin—Tension—Doxorubicin—kidney cancer	8.01e-05	0.00027	CcSEcCtD
Oxybutynin—Vomiting—Paclitaxel—kidney cancer	8e-05	0.00027	CcSEcCtD
Oxybutynin—Dysgeusia—Doxorubicin—kidney cancer	7.99e-05	0.000269	CcSEcCtD
Oxybutynin—Rash—Paclitaxel—kidney cancer	7.94e-05	0.000267	CcSEcCtD
Oxybutynin—Dermatitis—Paclitaxel—kidney cancer	7.93e-05	0.000267	CcSEcCtD
Oxybutynin—Nervousness—Doxorubicin—kidney cancer	7.92e-05	0.000267	CcSEcCtD
Oxybutynin—Back pain—Doxorubicin—kidney cancer	7.89e-05	0.000266	CcSEcCtD
Oxybutynin—Headache—Paclitaxel—kidney cancer	7.89e-05	0.000266	CcSEcCtD
Oxybutynin—Vision blurred—Doxorubicin—kidney cancer	7.69e-05	0.000259	CcSEcCtD
Oxybutynin—Hypersensitivity—Capecitabine—kidney cancer	7.61e-05	0.000256	CcSEcCtD
Oxybutynin—Ill-defined disorder—Doxorubicin—kidney cancer	7.57e-05	0.000255	CcSEcCtD
Oxybutynin—Agitation—Doxorubicin—kidney cancer	7.5e-05	0.000252	CcSEcCtD
Oxybutynin—Nausea—Paclitaxel—kidney cancer	7.48e-05	0.000252	CcSEcCtD
Oxybutynin—Asthenia—Capecitabine—kidney cancer	7.41e-05	0.00025	CcSEcCtD
Oxybutynin—Malaise—Doxorubicin—kidney cancer	7.36e-05	0.000248	CcSEcCtD
Oxybutynin—Syncope—Doxorubicin—kidney cancer	7.32e-05	0.000246	CcSEcCtD
Oxybutynin—Pruritus—Capecitabine—kidney cancer	7.31e-05	0.000246	CcSEcCtD
Oxybutynin—Palpitations—Doxorubicin—kidney cancer	7.21e-05	0.000243	CcSEcCtD
Oxybutynin—Loss of consciousness—Doxorubicin—kidney cancer	7.17e-05	0.000241	CcSEcCtD
Oxybutynin—Cough—Doxorubicin—kidney cancer	7.12e-05	0.00024	CcSEcCtD
Oxybutynin—Convulsion—Doxorubicin—kidney cancer	7.07e-05	0.000238	CcSEcCtD
Oxybutynin—Diarrhoea—Capecitabine—kidney cancer	7.07e-05	0.000238	CcSEcCtD
Oxybutynin—Hypertension—Doxorubicin—kidney cancer	7.04e-05	0.000237	CcSEcCtD
Oxybutynin—Arthralgia—Doxorubicin—kidney cancer	6.95e-05	0.000234	CcSEcCtD
Oxybutynin—Chest pain—Doxorubicin—kidney cancer	6.95e-05	0.000234	CcSEcCtD
Oxybutynin—Anxiety—Doxorubicin—kidney cancer	6.92e-05	0.000233	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.9e-05	0.000232	CcSEcCtD
Oxybutynin—Discomfort—Doxorubicin—kidney cancer	6.86e-05	0.000231	CcSEcCtD
Oxybutynin—Dizziness—Capecitabine—kidney cancer	6.83e-05	0.00023	CcSEcCtD
Oxybutynin—Dry mouth—Doxorubicin—kidney cancer	6.79e-05	0.000229	CcSEcCtD
Oxybutynin—Confusional state—Doxorubicin—kidney cancer	6.71e-05	0.000226	CcSEcCtD
Oxybutynin—Anaphylactic shock—Doxorubicin—kidney cancer	6.66e-05	0.000224	CcSEcCtD
Oxybutynin—Oedema—Doxorubicin—kidney cancer	6.66e-05	0.000224	CcSEcCtD
Oxybutynin—Infection—Doxorubicin—kidney cancer	6.62e-05	0.000223	CcSEcCtD
Oxybutynin—Vomiting—Capecitabine—kidney cancer	6.57e-05	0.000221	CcSEcCtD
Oxybutynin—Shock—Doxorubicin—kidney cancer	6.55e-05	0.000221	CcSEcCtD
Oxybutynin—Nervous system disorder—Doxorubicin—kidney cancer	6.53e-05	0.00022	CcSEcCtD
Oxybutynin—Rash—Capecitabine—kidney cancer	6.51e-05	0.000219	CcSEcCtD
Oxybutynin—Dermatitis—Capecitabine—kidney cancer	6.51e-05	0.000219	CcSEcCtD
Oxybutynin—Tachycardia—Doxorubicin—kidney cancer	6.5e-05	0.000219	CcSEcCtD
Oxybutynin—Headache—Capecitabine—kidney cancer	6.47e-05	0.000218	CcSEcCtD
Oxybutynin—Skin disorder—Doxorubicin—kidney cancer	6.47e-05	0.000218	CcSEcCtD
Oxybutynin—Anorexia—Doxorubicin—kidney cancer	6.35e-05	0.000214	CcSEcCtD
Oxybutynin—Hypotension—Doxorubicin—kidney cancer	6.22e-05	0.00021	CcSEcCtD
Oxybutynin—Nausea—Capecitabine—kidney cancer	6.14e-05	0.000207	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.07e-05	0.000204	CcSEcCtD
Oxybutynin—Insomnia—Doxorubicin—kidney cancer	6.02e-05	0.000203	CcSEcCtD
Oxybutynin—Paraesthesia—Doxorubicin—kidney cancer	5.98e-05	0.000201	CcSEcCtD
Oxybutynin—Somnolence—Doxorubicin—kidney cancer	5.92e-05	0.000199	CcSEcCtD
Oxybutynin—Dyspepsia—Doxorubicin—kidney cancer	5.86e-05	0.000197	CcSEcCtD
Oxybutynin—Decreased appetite—Doxorubicin—kidney cancer	5.79e-05	0.000195	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.75e-05	0.000194	CcSEcCtD
Oxybutynin—Fatigue—Doxorubicin—kidney cancer	5.74e-05	0.000193	CcSEcCtD
Oxybutynin—Constipation—Doxorubicin—kidney cancer	5.69e-05	0.000192	CcSEcCtD
Oxybutynin—Pain—Doxorubicin—kidney cancer	5.69e-05	0.000192	CcSEcCtD
Oxybutynin—Feeling abnormal—Doxorubicin—kidney cancer	5.49e-05	0.000185	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Doxorubicin—kidney cancer	5.45e-05	0.000183	CcSEcCtD
Oxybutynin—Urticaria—Doxorubicin—kidney cancer	5.29e-05	0.000178	CcSEcCtD
Oxybutynin—Abdominal pain—Doxorubicin—kidney cancer	5.26e-05	0.000177	CcSEcCtD
Oxybutynin—Hypersensitivity—Doxorubicin—kidney cancer	4.91e-05	0.000165	CcSEcCtD
Oxybutynin—Asthenia—Doxorubicin—kidney cancer	4.78e-05	0.000161	CcSEcCtD
Oxybutynin—Pruritus—Doxorubicin—kidney cancer	4.71e-05	0.000159	CcSEcCtD
Oxybutynin—Diarrhoea—Doxorubicin—kidney cancer	4.56e-05	0.000153	CcSEcCtD
Oxybutynin—Dizziness—Doxorubicin—kidney cancer	4.4e-05	0.000148	CcSEcCtD
Oxybutynin—Vomiting—Doxorubicin—kidney cancer	4.23e-05	0.000143	CcSEcCtD
Oxybutynin—Rash—Doxorubicin—kidney cancer	4.2e-05	0.000141	CcSEcCtD
Oxybutynin—Dermatitis—Doxorubicin—kidney cancer	4.19e-05	0.000141	CcSEcCtD
Oxybutynin—Headache—Doxorubicin—kidney cancer	4.17e-05	0.00014	CcSEcCtD
Oxybutynin—Nausea—Doxorubicin—kidney cancer	3.96e-05	0.000133	CcSEcCtD
Oxybutynin—CYP3A5—Metabolism—PTGS1—kidney cancer	8.16e-06	0.000412	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—FH—kidney cancer	8.1e-06	0.000409	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APRT—kidney cancer	8.1e-06	0.000409	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IGF1R—kidney cancer	8.04e-06	0.000406	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PSMD7—kidney cancer	8e-06	0.000404	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ANXA1—kidney cancer	7.98e-06	0.000403	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PSMD7—kidney cancer	7.98e-06	0.000403	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TSC1—kidney cancer	7.98e-06	0.000403	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PSMD7—kidney cancer	7.95e-06	0.000401	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ANXA1—kidney cancer	7.95e-06	0.000401	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TSC1—kidney cancer	7.95e-06	0.000401	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ANXA1—kidney cancer	7.88e-06	0.000397	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PSMD7—kidney cancer	7.88e-06	0.000397	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TSC1—kidney cancer	7.88e-06	0.000397	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—RAF1—kidney cancer	7.75e-06	0.000391	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FLT1—kidney cancer	7.73e-06	0.00039	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FLT1—kidney cancer	7.7e-06	0.000389	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—IL2—kidney cancer	7.65e-06	0.000386	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FLT1—kidney cancer	7.63e-06	0.000385	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.62e-06	0.000385	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GPC3—kidney cancer	7.62e-06	0.000384	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—BCHE—kidney cancer	7.58e-06	0.000383	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTT1—kidney cancer	7.54e-06	0.00038	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ACHE—kidney cancer	7.54e-06	0.00038	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—SLC5A5—kidney cancer	7.49e-06	0.000378	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CA2—kidney cancer	7.41e-06	0.000374	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CRABP1—kidney cancer	7.3e-06	0.000368	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—POMC—kidney cancer	7.29e-06	0.000368	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—POMC—kidney cancer	7.26e-06	0.000366	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—SLC2A1—kidney cancer	7.23e-06	0.000365	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALAD—kidney cancer	7.22e-06	0.000364	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—POMC—kidney cancer	7.19e-06	0.000363	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GSTP1—kidney cancer	7.18e-06	0.000362	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PAK1—kidney cancer	7.16e-06	0.000361	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—JUNB—kidney cancer	7.16e-06	0.000361	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—JUNB—kidney cancer	7.14e-06	0.00036	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PAK1—kidney cancer	7.14e-06	0.00036	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—SCARB1—kidney cancer	7.14e-06	0.00036	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—JUNB—kidney cancer	7.07e-06	0.000357	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PAK1—kidney cancer	7.07e-06	0.000357	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS1—kidney cancer	7.07e-06	0.000356	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.05e-06	0.000355	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—IL2—kidney cancer	6.95e-06	0.000351	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PSMD7—kidney cancer	6.93e-06	0.00035	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.89e-06	0.000347	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ABCB1—kidney cancer	6.79e-06	0.000343	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ITPR2—kidney cancer	6.79e-06	0.000342	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HIF1A—kidney cancer	6.62e-06	0.000334	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—POMC—kidney cancer	6.62e-06	0.000334	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TSC2—kidney cancer	6.61e-06	0.000333	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PGK1—kidney cancer	6.6e-06	0.000333	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.6e-06	0.000333	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—POMC—kidney cancer	6.6e-06	0.000333	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GSTM1—kidney cancer	6.59e-06	0.000333	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—BCHE—kidney cancer	6.57e-06	0.000331	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—POMC—kidney cancer	6.53e-06	0.00033	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—SLC5A5—kidney cancer	6.49e-06	0.000327	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—LDHB—kidney cancer	6.48e-06	0.000327	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KDR—kidney cancer	6.33e-06	0.000319	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—SLC2A1—kidney cancer	6.27e-06	0.000316	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CYP1A1—kidney cancer	6.25e-06	0.000315	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTT1—kidney cancer	6.19e-06	0.000312	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ACHE—kidney cancer	6.19e-06	0.000312	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.08e-06	0.000307	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTP1—kidney cancer	6.03e-06	0.000304	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SCARB1—kidney cancer	5.86e-06	0.000296	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IGF2—kidney cancer	5.86e-06	0.000295	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IGF2—kidney cancer	5.84e-06	0.000295	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KIT—kidney cancer	5.83e-06	0.000294	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—APC—kidney cancer	5.83e-06	0.000294	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	5.83e-06	0.000294	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	5.81e-06	0.000293	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS1—kidney cancer	5.8e-06	0.000293	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IGF2—kidney cancer	5.78e-06	0.000292	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	5.76e-06	0.00029	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ABCB1—kidney cancer	5.71e-06	0.000288	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PSMD7—kidney cancer	5.69e-06	0.000287	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IGF1R—kidney cancer	5.66e-06	0.000286	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IGF1R—kidney cancer	5.65e-06	0.000285	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CA9—kidney cancer	5.61e-06	0.000283	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IGF1R—kidney cancer	5.59e-06	0.000282	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—MAPK3—kidney cancer	5.59e-06	0.000282	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—POMC—kidney cancer	5.55e-06	0.00028	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTM1—kidney cancer	5.54e-06	0.00028	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—BRAF—kidney cancer	5.48e-06	0.000277	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—RAF1—kidney cancer	5.46e-06	0.000275	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—RAF1—kidney cancer	5.44e-06	0.000274	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—BCHE—kidney cancer	5.39e-06	0.000272	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—IL2—kidney cancer	5.39e-06	0.000272	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—RAF1—kidney cancer	5.39e-06	0.000272	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—IL2—kidney cancer	5.37e-06	0.000271	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SLC5A5—kidney cancer	5.33e-06	0.000269	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—IL2—kidney cancer	5.32e-06	0.000268	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—MAPK1—kidney cancer	5.32e-06	0.000268	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.3e-06	0.000267	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CYP1A1—kidney cancer	5.26e-06	0.000265	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTP1—kidney cancer	5.23e-06	0.000264	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SLC2A1—kidney cancer	5.14e-06	0.00026	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—PIK3CA—kidney cancer	5.08e-06	0.000256	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—KRAS—kidney cancer	5.02e-06	0.000253	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ABCB1—kidney cancer	4.95e-06	0.00025	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL2—kidney cancer	4.89e-06	0.000247	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL2—kidney cancer	4.88e-06	0.000246	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL2—kidney cancer	4.83e-06	0.000244	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTM1—kidney cancer	4.8e-06	0.000242	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CRABP1—kidney cancer	4.77e-06	0.000241	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HIF1A—kidney cancer	4.66e-06	0.000235	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—POMC—kidney cancer	4.66e-06	0.000235	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TSC2—kidney cancer	4.65e-06	0.000235	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HIF1A—kidney cancer	4.65e-06	0.000234	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TSC2—kidney cancer	4.64e-06	0.000234	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—PIK3CA—kidney cancer	4.61e-06	0.000233	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HIF1A—kidney cancer	4.6e-06	0.000232	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TSC2—kidney cancer	4.59e-06	0.000232	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RAF1—kidney cancer	4.58e-06	0.000231	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RELA—kidney cancer	4.56e-06	0.00023	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP1A1—kidney cancer	4.55e-06	0.00023	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ERBB2—kidney cancer	4.53e-06	0.000228	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MTOR—kidney cancer	4.47e-06	0.000225	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KDR—kidney cancer	4.46e-06	0.000225	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KDR—kidney cancer	4.44e-06	0.000224	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ITPR2—kidney cancer	4.44e-06	0.000224	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KDR—kidney cancer	4.4e-06	0.000222	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTP1—kidney cancer	4.29e-06	0.000216	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CDKN1B—kidney cancer	4.19e-06	0.000212	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APC—kidney cancer	4.11e-06	0.000207	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KIT—kidney cancer	4.11e-06	0.000207	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL2—kidney cancer	4.11e-06	0.000207	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KIT—kidney cancer	4.09e-06	0.000207	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APC—kidney cancer	4.09e-06	0.000207	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ABCB1—kidney cancer	4.06e-06	0.000205	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APC—kidney cancer	4.05e-06	0.000205	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KIT—kidney cancer	4.05e-06	0.000205	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ACHE—kidney cancer	4.05e-06	0.000204	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTT1—kidney cancer	4.05e-06	0.000204	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCND1—kidney cancer	4e-06	0.000202	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—JUN—kidney cancer	3.99e-06	0.000201	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CTNNB1—kidney cancer	3.96e-06	0.0002	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTM1—kidney cancer	3.94e-06	0.000199	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	3.93e-06	0.000198	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	3.92e-06	0.000198	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—POMC—kidney cancer	3.92e-06	0.000198	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—POMC—kidney cancer	3.91e-06	0.000197	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—POMC—kidney cancer	3.9e-06	0.000197	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	3.88e-06	0.000196	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PTEN—kidney cancer	3.86e-06	0.000195	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—BRAF—kidney cancer	3.86e-06	0.000195	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—POMC—kidney cancer	3.86e-06	0.000195	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—BRAF—kidney cancer	3.85e-06	0.000194	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SCARB1—kidney cancer	3.83e-06	0.000193	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—BRAF—kidney cancer	3.81e-06	0.000192	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS1—kidney cancer	3.79e-06	0.000191	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	3.74e-06	0.000189	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.74e-06	0.000189	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.74e-06	0.000189	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	3.73e-06	0.000188	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PSMD7—kidney cancer	3.72e-06	0.000188	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—kidney cancer	3.72e-06	0.000188	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	3.69e-06	0.000186	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	3.58e-06	0.00018	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	3.57e-06	0.00018	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—KRAS—kidney cancer	3.54e-06	0.000178	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	3.53e-06	0.000178	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—BCHE—kidney cancer	3.53e-06	0.000178	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—KRAS—kidney cancer	3.52e-06	0.000178	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—KRAS—kidney cancer	3.49e-06	0.000176	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—kidney cancer	3.49e-06	0.000176	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.48e-06	0.000176	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—POMC—kidney cancer	3.39e-06	0.000171	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.36e-06	0.00017	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK3—kidney cancer	3.3e-06	0.000166	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	3.25e-06	0.000164	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTEN—kidney cancer	3.24e-06	0.000164	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	3.24e-06	0.000163	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RAF1—kidney cancer	3.22e-06	0.000163	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RAF1—kidney cancer	3.21e-06	0.000162	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MYC—kidney cancer	3.21e-06	0.000162	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RELA—kidney cancer	3.21e-06	0.000162	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	3.21e-06	0.000162	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RELA—kidney cancer	3.2e-06	0.000161	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ERBB2—kidney cancer	3.19e-06	0.000161	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RAF1—kidney cancer	3.18e-06	0.000161	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ERBB2—kidney cancer	3.18e-06	0.00016	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RELA—kidney cancer	3.17e-06	0.00016	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ERBB2—kidney cancer	3.15e-06	0.000159	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MTOR—kidney cancer	3.15e-06	0.000159	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK1—kidney cancer	3.14e-06	0.000158	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MTOR—kidney cancer	3.14e-06	0.000158	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—kidney cancer	3.13e-06	0.000158	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MTOR—kidney cancer	3.11e-06	0.000157	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KRAS—kidney cancer	2.97e-06	0.00015	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	2.95e-06	0.000149	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	2.94e-06	0.000149	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	2.92e-06	0.000147	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL2—kidney cancer	2.89e-06	0.000146	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL2—kidney cancer	2.88e-06	0.000145	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL2—kidney cancer	2.85e-06	0.000144	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCND1—kidney cancer	2.82e-06	0.000142	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—JUN—kidney cancer	2.81e-06	0.000142	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCND1—kidney cancer	2.81e-06	0.000142	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTP1—kidney cancer	2.81e-06	0.000142	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—JUN—kidney cancer	2.8e-06	0.000141	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	2.79e-06	0.000141	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—POMC—kidney cancer	2.79e-06	0.000141	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCND1—kidney cancer	2.78e-06	0.00014	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	2.78e-06	0.00014	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—JUN—kidney cancer	2.78e-06	0.00014	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	2.75e-06	0.000139	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTEN—kidney cancer	2.73e-06	0.000138	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	2.72e-06	0.000137	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PTEN—kidney cancer	2.72e-06	0.000137	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PTEN—kidney cancer	2.71e-06	0.000137	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—kidney cancer	2.71e-06	0.000137	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTEN—kidney cancer	2.68e-06	0.000135	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCB1—kidney cancer	2.66e-06	0.000134	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—kidney cancer	2.64e-06	0.000133	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTM1—kidney cancer	2.58e-06	0.00013	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—kidney cancer	2.46e-06	0.000124	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—kidney cancer	2.45e-06	0.000124	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.44e-06	0.000123	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—kidney cancer	2.42e-06	0.000122	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTEN—kidney cancer	2.36e-06	0.000119	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK3—kidney cancer	2.32e-06	0.000117	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK3—kidney cancer	2.32e-06	0.000117	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK3—kidney cancer	2.29e-06	0.000116	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CA—kidney cancer	2.29e-06	0.000115	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MYC—kidney cancer	2.26e-06	0.000114	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MYC—kidney cancer	2.25e-06	0.000114	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MYC—kidney cancer	2.23e-06	0.000113	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—kidney cancer	2.22e-06	0.000112	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK1—kidney cancer	2.21e-06	0.000112	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK1—kidney cancer	2.2e-06	0.000111	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK1—kidney cancer	2.18e-06	0.00011	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KRAS—kidney cancer	2.09e-06	0.000105	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KRAS—kidney cancer	2.08e-06	0.000105	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KRAS—kidney cancer	2.06e-06	0.000104	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTEN—kidney cancer	1.94e-06	9.78e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.92e-06	9.7e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1.92e-06	9.68e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.91e-06	9.65e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.89e-06	9.55e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—kidney cancer	1.86e-06	9.36e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—kidney cancer	1.85e-06	9.33e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—kidney cancer	1.83e-06	9.24e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—POMC—kidney cancer	1.82e-06	9.19e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.67e-06	8.4e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—kidney cancer	1.45e-06	7.33e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.37e-06	6.9e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTEN—kidney cancer	1.27e-06	6.39e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.94e-07	4.51e-05	CbGpPWpGaD
